Form 4 · Filed Jul 1, 2026, 09:04 PM UTC
IBRX/ImmunityBio, Inc.
Selecky Christobel — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
12 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | M | other | 300 | — | — | 124,414 |
| Jun 30, 2026 | M | other | 700 | $3 | $2,086 | 700 |
| Jun 30, 2026 | M | other | 300 | $3 | $897 | 1,000 |
| Jun 30, 2026 | S | sell | 1,000 | $9 | $9,000 | 0 |
| Jun 30, 2026 | M | other | 700 | — | — | 35,064 |
| Jun 29, 2026 | M | other | 30,000 | — | — | 132,786 |
| Jun 29, 2026 | M | other | 32,173 | $3 | $95,876 | 32,173 |
| Jun 29, 2026 | M | other | 32,173 | — | — | 35,764 |
| Jun 29, 2026 | M | other | 33,549 | $3 | $100,312 | 65,722 |
| Jun 29, 2026 | M | other | 30,000 | $3 | $85,200 | 95,722 |
| Jun 29, 2026 | S | sell | 95,722 | $9 | $862,216 | 0 |
| Jun 29, 2026 | M | other | 33,549 | — | — | 124,714 |
Source: SEC EDGAR raw filing ↗ · Accession 0001849739-26-000011